These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32652700)

  • 41. Steroid withdrawal in renal transplant recipients: pro point of view.
    Hricik DE
    Transplant Proc; 1998 Jun; 30(4):1380-2. PubMed ID: 9636559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation.
    Freise CE; Kang SM; Feng S; Posselt A; Hirose K; Hirose R; Stock P
    Transplant Proc; 2004 May; 36(4):1067-8. PubMed ID: 15194370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and post-transplant diabetes.
    Humar A; Crotteau S; Gruessner A; Kandaswamy R; Gruessner R; Payne W; Lake J
    Clin Transplant; 2007; 21(4):526-31. PubMed ID: 17645714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of everolimus in reducing cytomegalovirus events in kidney transplant recipients on steroid-avoidance strategy: 3-year follow-up of a randomized clinical trial.
    de Sandes-Freitas TV; Pinheiro PMA; Sales MLMBO; Girão CM; Campos ÉF; Esmeraldo RM
    Transpl Int; 2018 Dec; 31(12):1345-1356. PubMed ID: 29969826
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tacrolimus-based immunosuppression with steroid withdrawal in pediatric kidney transplantation--4-year experience at a moderate-volume center.
    Jensen S; Jackson EC; Riley L; Reddy S; Goebel J
    Pediatr Transplant; 2003 Apr; 7(2):119-24. PubMed ID: 12654052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis.
    Stratta RJ; Alloway RR; Hodge E; Lo A;
    Clin Transplant; 2002 Feb; 16(1):60-8. PubMed ID: 11982617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-benefit of steroid avoidance in renal transplant patients: a prospective randomized study.
    Gheith OA; Nematalla AH; Bakr MA; Refaie A; Shokeir AA; Ghoneim MA
    Scand J Urol Nephrol; 2010 Apr; 44(3):175-82. PubMed ID: 20230185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An update on chemical pharmacotherapy options for the prevention of kidney transplant rejection with a focus on costimulation blockade.
    Kälble F; Schaier M; Schäfer S; Süsal C; Zeier M; Sommerer C; Morath C
    Expert Opin Pharmacother; 2017 Jun; 18(8):799-807. PubMed ID: 28460546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early steroid withdrawal in solitary pancreas transplantation results in equivalent graft and patient survival compared with maintenance steroid therapy.
    Vessal G; Wiland AM; Philosophe B; Fink JC; Weir MR; Klassen DK
    Clin Transplant; 2007; 21(4):491-7. PubMed ID: 17645708
    [TBL] [Abstract][Full Text] [Related]  

  • 50. De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco.
    Vincenti F; Stock P
    Transplant Proc; 2003 May; 35(3 Suppl):183S-186S. PubMed ID: 12742494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Review of immunosuppressive usage in pancreas transplantation.
    Stratta RJ
    Clin Transplant; 1999 Feb; 13(1 Pt 1):1-12. PubMed ID: 10081628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer risk and mortality after kidney transplantation: a population-based study on differences between Danish centres using standard immunosuppression with and without glucocorticoids.
    Engberg H; Wehberg S; Bistrup C; Heaf J; Sørensen SS; Thiesson HC; Hansen JM; Svensson M; Green A; Marckmann P
    Nephrol Dial Transplant; 2016 Dec; 31(12):2149-2156. PubMed ID: 27587604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients.
    Locke JE; James NT; Mannon RB; Mehta SG; Pappas PG; Baddley JW; Desai NM; Montgomery RA; Segev DL
    Transplantation; 2014 Feb; 97(4):446-50. PubMed ID: 24162248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression.
    Rajab A; Pelletier RP; Henry ML; Ferguson RM
    Clin Transplant; 2006; 20(5):537-46. PubMed ID: 16968478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Excellent outcomes can be achieved in young pancreas transplant alone recipients by addition of sirolimus to maintenance immunosuppression regimen.
    Porubsky M; Gruessner AC; Rana A; Jie T; Gruessner RW
    Transplant Proc; 2014; 46(6):1932-5. PubMed ID: 25131074
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluating the Incidence and Risk Factors for Acute Cellular Rejection in a Steroid Sparing Liver Transplant Center.
    Zhang X; Lichvar A; Chan C; Choi D
    Ann Pharmacother; 2023 May; 57(5):553-559. PubMed ID: 36004388
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation.
    Freise CE; Kang SM; Feng S; Hirose R; Stock P
    Arch Surg; 2003 Oct; 138(10):1121-5; discussion 1125-6. PubMed ID: 14557130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Steroid avoidance in renal transplantation.
    Lightner A; Concepcion W; Grimm P
    Curr Opin Organ Transplant; 2011 Oct; 16(5):477-82. PubMed ID: 21844809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Belatacept Compared With Tacrolimus for Kidney Transplantation: A Propensity Score Matched Cohort Study.
    Cohen JB; Eddinger KC; Forde KA; Abt PL; Sawinski D
    Transplantation; 2017 Oct; 101(10):2582-2589. PubMed ID: 27941427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.